SurModics to Webcast Second Quarter 2015 Earnings Conference Call on April 30
April 21 2015 - 8:00AM
Business Wire
Webcast is Live at 4:00 p.m. (CT)
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its
second quarter 2015 conference call on Thursday, April 30, at 4:00
p.m. CT (5:00 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and chief financial officer,
will recap the second quarter 2015 financial results and
accomplishments. To access the webcast, go to the investor
relations portion of the Company’s website at www.surmodics.com the
day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on
Thursday, April 30, until 7:00 p.m. CT on Thursday, May 7, and
can be accessed by dialing 888-203-1112 and entering conference
call ID passcode 8699575. In addition, the conference call audio
and transcript will be archived on the Company’s website following
the call.
About SurModics, Inc.SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed
to improve lives by enabling the detection and treatment of
disease. Our mission is to be a trusted partner to our customers by
providing the most advanced surface modification technologies and
in vitro diagnostic chemical components that help enhance the
well-being of patients. The company’s core offerings include
surface modification coating technologies that impart lubricity,
prohealing and biocompatibility characteristics and components for
in vitro diagnostic test kits and microarrays. SurModics is
headquartered in Eden Prairie, Minnesota. For more information
about the Company, visit www.surmodics.com. The content of
SurModics’ website is not part of this press release or part of any
filings that the Company makes with the SEC.
SurModics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024